In February 2016, findings were published in The Journal of the American Medical Association after a task force with expertise in sepsis pathobiology, clinical trials, and epidemiology came together to study current sepsis information. The task force was formed by the Society of Critical Care Medicine and the European society of Intensive Care Medicine (Angus & Singer, 2016, p. 801).
Definitions and clinical criteria were reevaluated and assessed and then finally a lot of septic issues were rewritten or made increasingly clear.
Key Findings of the Taskforce are:
· It is now misleading to excessively focus on inflammation when dealing with sepsis.
· It is now misleading to depend on the SIRS criteria models.
· Many of the current sepsis definitions were found to be redundant and it was recommended they not be used any longer. i.e., ‘Severe Sepsis’
Understanding sepsis more in depth requires one to understand that sepsis is a syndrome of biochemical abnormalities, pathologic and physiological abnormalities that is induced by infection. In the United States alone sepsis accounted for more than $20 Billion in total US hospital costs in 2011 (Angus & Singer, 2016).
Sepsis is now the leading cause of death in the hospitalized patient (Deutschman & Tracey, 2014, p. 463). Sepsis now has over 1,000,000 new cases annually within the United States, and unlike most illnesses, it has up to a 50% mortality rate (Deutschman & Tracey, 2014)
There is no specific treatment for sepsis, no specific medications for sepsis and sepsis drains billions from society due to the patient having to spend weeks and sometimes months with hospitalization. There is no specific patient with sepsis, it spans across all age groups, nationalities, genders, etc.
0 comments:
Post a Comment